Advocacy in the pharma industry is crucial—but are teams and budgets keeping up with the demand?
Our latest video uncovers surprising insights from the BIOADVOCATE BENCHMARK and ELAVAY report, showing how underfunded and understaffed many advocacy efforts are. Despite this, organizations are achieving amazing results—but imagine what they could do with the right resources.
In this video, you’ll learn:
How much do pharma companies spend on advocacy (spoiler: it’s shockingly low)?
Why many organizations are working with a third of the teams and budgets they need.
How data-driven strategies can reshape advocacy efforts and build trust in patient communities.
👉 Watch the video now and discover how to align your advocacy strategy with industry benchmarks for maximum impact.
Best regards,
Matt Toresco